Posters
Comparison of clinical outcomes of penetrating keratoplasty and DSAEK in combined surgery
Poster Details
First Author: L.Saad ALGERIA
Co Author(s): L. Degdeg A. Hichem S. Allaeddine A. Omar R. Mounir H. Faycel
Abstract Details
Purpose:
To evaluate the longer-term clinical outcomes and graft survival up to 03 years of patients rehabilitated by combined surgery for corneal disease and cataract or aphakia without capsule support. divided in 02 groups: penetrating keratoplasty (PK), endothelial graft type DSAEK. [best-corrected visual acuity (BCVA), central endothelial cell density (ECD), Survival probability was calculated, per and postoperative complications were documented.
Setting:
Prospective, interventional case series conducted at the Military university hospital of Constantine, Algeria
Methods:
20 patients suffered from: post-traumatic corneal scar and cataract 20%, corneal scar secondary to anterior chamber implant (ICA) 5%, corneal scar post phacoemulsification (PKE) 5%, endothelial dysfunction secondary to ICA 20%, stromal dystrophy and cataract 20%, endothelial dysfunction post PKE 15%, Fuchs’ dystrophy and cataract 10%, keratoconus and cataract 5%. 60% were phakic and 40 % patients were aphakic.
Results:
Mean age 66,09+12,86 years. 35% mal, 65% female. 50% underwent triple procedure (PK), extracapsular lens extraction and IOL implantation, 15% PK and posterior IOL iris claw. 10% PKE, DSAEK and IOL implantation. 25% IOL exchange, posterior Iris claw and DSAEK.65% of patients underwent PK and 35% DSAEK. The mean BSCVA in snellen scale respectively in the group PK and DSAEK (0,46 + 0,10), (0,39 + 0,21). PK group: 01 case of capsular break, 10% graft rejection, 10 % peripheral corneal abscise well recovered after treatment. 01 case of graft detachment occurred in DSAEK group resolved after rebubbling. ECD loss PK(40,77%) DASEK (44,29 ). Rate survival at 03 years is 100% in both groups.
Conclusions:
03 years follow-up show very high rate of graft survival, good visual outcomes in both groups, but with more preoperative and postoperative complications in the group of PK.
Financial Disclosure:
None